Strategic Radiology member groups now have enhanced abilities to offer NeuroQuant in their practices, a powerful MRI post-processing tool for quantifying brain atrophy, helpful to referring physicians in their assessment of neurodegenerative disorders.
July 29, 2014 – Cortechs.ai, a leading medical software innovator providing solutions for quantitative brain volume analysis and Strategic Radiology (SR), an affiliation of 17 independent radiology group practices dispersed across the US, are pleased to announce the signing of a preferred partnership agreement on NeuroQuant.
“Cortechs.ai is widely recognized within the healthcare industry as a provider of innovative medical imaging solutions and their NeuroQuant® product is an excellent example of this leadership position,” said Arl Van Moore, MD, Chairman and CEO of SR. “Having this advanced imaging tool will provide neurologists and radiologists with objective support for their clinical impression, which will be very important to SR member groups’ referring physician network. Together, this partnership has the real opportunity to advance the level of neuroscience patient care on a national scale.”
Through this agreement Cortechs.ai will provide their FDA 510(k) cleared MRI post-processing tool NeuroQuant to SR to further enhance their radiologists’ ability to provide more quantitative measurements of brain atrophy in neurodegenerative diseases such as Alzheimer’s disease, epilepsy, TBI, and multiple sclerosis.
“We are very excited to enable preferred access to Strategic Radiology and their member groups who choose NeuroQuant for the physicians and patients who put their trust in them,” said Guri Stark, CEO of Cortechs.ai. “As a key luminary federation of radiology groups, SR has an incredible network of sites in key regions of the United States. The ability to offer NeuroQuant in these important centers can enhance their clinical assessments by providing quantitative brain volume measurements.”
About Strategic Radiology
SR consists of geographically diverse and forward thinking radiology group practices representing more than 1,200 radiologists. The goal of SR is to achieve higher quality patient care and more cost efficient delivery of medical imaging through an integrated approach of shared data and best practices, interchanging clinical expertise, and consolidating certain practice expenses. More information can be found on the SR website at http://www.strategicradiology.org.
Current SR members include:
Advanced Radiology Services, Grand Rapids, MI; Austin Radiological Association, Austin, TX; Central Illinois Radiological Associates, Peoria, IL; Charlotte Radiology, Charlotte, NC; Diversified Radiology, Denver, CO; Inland Imaging, Spokane, WA; Jefferson Radiology, Hartford, CT; Mountain Medical Physician Specialists, Salt Lake City, UT; Northwest Radiology, Indianapolis, IN; Quantum Radiology, Atlanta, GA; Radiant Imaging, Inc., Pasadena, CA (affiliates: The Hill Medical Corporation; Arcadia Radiology Medical Group); Radiology Associates of North Texas, Fort Worth, TX; Radiology Associates of South Florida, Miami, FL; Radiology Ltd., Tucson, AZ; Riverside Radiology and Interventional Associates, Columbus, OH; Southwest Diagnostic Imaging, Phoenix, AZ and affiliates Scottsdale Medical Imaging and Valley Radiologists); University Radiology, East Brunswick, NJ.
About Cortechs.ai, Inc.
Cortechs.ai develops and markets cutting-edge brain imaging solutions used by neurologists and radiologists in hundreds of clinics and research centers around the world. CorTechs’ flagship product, NeuroQuant®, is a breakthrough, 510(k)-cleared and CE-Marked software medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the first FDA-cleared medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician’s desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost effective means to quantify atrophy of brain structures to help in the assessment of a variety of neurodegenerative brain disorders, including conditions such as Alzheimer’s disease, epilepsy, multiple sclerosis, and traumatic brain injury. For more information about NeuroQuant and Cortechs.ai, please visit, cortechs.ai.
Media Contact:
Shelly Adams
Cortechs.ai, Inc.
858-479-9700
sadams@cortechs.ai
